Market Cap 738.45M P/E - EPS this Y 57.50% Ern Qtrly Grth -
Income -27.71M Forward P/E -21.85 EPS next Y -17.60% 50D Avg Chg 8.00%
Sales 105.57M PEG -0.32 EPS past 5Y - 200D Avg Chg 43.00%
Dividend N/A Price/Book 14.47 EPS next 5Y 70.00% 52W High Chg -21.00%
Recommedations 1.70 Quick Ratio 2.56 Shares Outst. 168.98M 52W Low Chg 255.00%
Insider Own 0.31% ROA -12.31% Shares Float 168.46M Beta 1.44
Inst Own 85.26% ROE -46.23% Short Shares 0 Price 4.37
Gross Margin 43.20% Profit Margin -26.25% Avg. Volume 3,547,960 Target Price 8.50
Oper. Margin -26.03% Earnings Mar 2 Volume 4,928,908 Change 7.11%
Rigel Pharmaceuticals, Inc. News
02/23/21 Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2020 Financial Results and Business Update
02/21/21 3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring
02/18/21 Why Rigel Pharmaceuticals Stock Is Jumping Today
02/18/21 Rigel Partners With Eli Lilly On Therapy For Autoimmune Disorders; Stock Pops 15%
02/18/21 The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
02/18/21 UPDATE 1-Eli Lilly in deal with Rigel to develop autoimmune therapy for up to $960 mln
02/18/21 Rigel Pharma shares soar 39% premarket on news of deal with Eli Lilly
02/18/21 Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treatment of Immunological and Neurodegenerative Diseases
02/18/21 Rigel Pharmaceuticals Rises on Drug Venture With Eli Lilly
01/29/21 Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
01/29/21 If You Had Bought Rigel Pharmaceuticals (NASDAQ:RIGL) Stock A Year Ago, You Could Pocket A 49% Gain Today
01/22/21 This former Michigan State University basketball player started selling mortgages in his 20s now he's worth more than $11 billion
01/11/21 Rigel Pharmaceuticals Provides Business Update
01/07/21 Rigel to Present at the 39th Annual J.P. Morgan Healthcare Conference
12/21/20 Is the Options Market Predicting a Spike in Rigel Pharmaceuticals (RIGL) Stock?
12/19/20 Is RIGL A Good Stock To Buy Now According To Hedge Funds?
12/15/20 What Type Of Shareholders Own The Most Number of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares?
12/04/20 Rigel Announces Two Posters Highlighting TAVALISSE at the 62nd ASH Annual Meeting & Exposition
11/23/20 Rigel and Medison Announce Health Canada Approval of TAVALISSE®, an Oral Medication for the Treatment of Adults with Chronic Immune Thrombocytopenia

Rigel Pharmaceuticals, Inc., a biotechnology company, engages in the discovery and development of small molecule drugs for the treatment of immune and hematologic disorders, cancer, and rare diseases. The company's clinical programs include Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; and Phase III clinical study for autoimmune hemolytic anemia. Its clinical programs also comprise R835, a proprietary molecule from its interleukin receptor associated kinase (IRAK) program, which is in Phase I clinical study for autoimmune and inflammatory diseases. The company has research and license agreements with Aclaris Therapeutics International Limited for the development and commercialization of janus kinase (JAK) inhibitors for the treatment of alopecia areata and other dermatological conditions; AstraZeneca AB for the development and commercialization of R256, an inhaled JAK inhibitor; BerGenBio AS for the development and commercialization of AXL inhibitors in oncology; and Daiichi Sankyo to pursue research related to MDM2 inhibitors, a novel class of drug targets called ligases, as well as license and supply agreement with Kissei Pharmaceutical Co., Ltd. to develop and commercialize Tavalisse. Rigel Pharmaceuticals, Inc. was incorporated in 1996 and is based in South San Francisco, California.

RIGL Chatroom

User Image joNANOthan Posted - 12 minutes ago

$RIGL Merck just acquired Pandion Therapeutics, Inc for $1.85 billion. Pandion's most advanced program focused on autoimmune diseases has not yet entered Phase 2 studies. In comparison, Rigel sits on an IRAK 1-4 program with massive promise (unpartnered and Phase 2 ready) that could easily support a premium like this (and more)....especially if you add in the RIP1 program (partnered with Lilly in a $125M up and $835 potential milestones + royalties deal). That must mean that we are getting FOR FREE fostamatinib that is already marketed in ITP, fostamatinib that is in a robust Phase 3 trials in wAIHA, fostamatinib that is in Phase 2 and 3 studies for Covid-19/ARDS and the BergenBio, Daiichi and AZ partnerships....truly for free. Oh and our drug discovery engine that is capable of churning out leads with no problem. AND our balance sheet has in excess of $160M in cash. Seriously, when you see Pandion get bought for $1.85B it tells you that our valuation is simply way too low.

User Image EtradrNControl Posted - 23 minutes ago

@truththetrue je hebt een geweldige dag $RIGL

User Image EtradrNControl Posted - 24 minutes ago

@truththetrue Allemaal over Regal Theraputics vandaag. verzameld op dinsdag. $RIGL

User Image Mao9 Posted - 50 minutes ago

$RIGL 20.00

User Image tomengine Posted - 56 minutes ago

$RIGL Rigel primed for a breakout 2021; everything you need to know. https://www.reddit.com/r/pennystocks/comments/lo5xdw/rigel_pharmaceuticals_primed_for_breakout_2021/

User Image Mao9 Posted - 1 hour ago

$RIGL

User Image Berakhot Posted - 1 hour ago

$RIGL Top of the Morning all you RIGL Rollers :) Have a good day!

User Image EtradrNControl Posted - 1 hour ago

$RIGL ok we all know $LLY is going to make Bank on $RIGL So let’s continue to accumulate Rigel. Patience = Rewards. That’s what $LLY ’s Stockholders are banking on.

User Image EtradrNControl Posted - 1 hour ago

$RIGL just warming up.

User Image Mao9 Posted - 1 hour ago

$RIGL lets s rock!

User Image dameonwalwyn Posted - 1 hour ago

$RIGL riggle raggle🎸💪🏾

User Image AmericaStocksFirst Posted - 1 hour ago

$RIGL do not watch what’s going on in the last 7 days. change your view in 1 year. My view is 103% up!

User Image Swiss_Toni Posted - 5 hours ago

Bottom Finder Alert: $RIGL This Russell stock is a Buy! Join my Discord for free alerts and chat. https://elite.finviz.com/chart.ashx?t=RIG

User Image mackinvestor Posted - 6 hours ago

$RIGL 125M in upfront cash from $LLY to $RIGL; 835M in additional milestones plus royalties. Importantly, in the $LLY deal, $RIGL didn't have to dilute or issue stock to $LLY (like $LLY extracted in the deal with old $RXDX). US rights to the RIP inhibitor R552, which is going to be decisive IMHO.

User Image Stock_Savage Posted - 9 hours ago

$NSPX $SKYE $PAOG $RIGL $LPCN Why would they do this? Because it’s about to pay off. IMO https://www.google.com/amp/s/finance.yahoo.com/amphtml/news/inspyr-therapeutics-further-strengthens-global-164000098.html

User Image mackinvestor Posted - 9 hours ago

$RIGL Covid trial for repurposing fostamatinib is being funded by the US Department of Defense (DoD) so I see little risk in that endeavor. 125M from Eli Lilly $LLY to $RIGL for Rigel's RIP inhibitors is a huge vote of confidence and strength. Lilly $LLY is very careful and diligent with its partnerships, and Lilly has a track record of partnering with biotech winners/stars. Remember old $RXDX (Ignyta)? Lilly signed a validating (and legitimizing) partnership with Ignyta in November 2015: https://www.businesswire.com/news/home/20151108005038/en/Ignyta-Announces-Acquisition-of-Exclusive-Rights-to-Taladegib-Oncology-Program-from-Lilly Ignyta was acquired for 1.7B by Roche in December 2017. https://www.fiercebiotech.com/biotech/roche-splashes-1-7b-cash-for-ignyta-and-entrectinib

User Image bluediamonds Posted - 10 hours ago

$RIGL fun reads on this board lol goodnight y'all

User Image EtradrNControl Posted - 11 hours ago

$GME take your gains/profits to $RIGL or $LLY

User Image EtradrNControl Posted - 11 hours ago

$LLY Could or Would $LLY acquire $RIGL ? Just a asking!

User Image Bsbl Posted - 12 hours ago

$RIGL I am not technologically savvy. One page of the buys for the naysayers. I am in and will hold. When I sell I will announce it but we are nowhere close to that

User Image shariffivdb Posted - 12 hours ago

$RIGL Great! It’s now $4.43.

User Image Bsbl Posted - 12 hours ago

$RIGL

User Image Malcolmh404 Posted - 12 hours ago

$RIGL $AMC $GME let’s ride

User Image Mao9 Posted - 12 hours ago

$RIGL welcome to the club gtc 20.00

User Image DosGatos Posted - 13 hours ago

$RIGL 👇 this cat has 500k+ in rigl but can’t come up with a better name than bbbbsBl!

User Image Bsbl Posted - 13 hours ago

$RIGL so some guy talked about ballers not being on Stocktwits. I do not consider myself a baller. I have now 154,000 shares of Rigl because I believe in it. Just bought 4,000 shares at 4.41 which is why it went from 4.31 to 4.41. I am on Stocktwits because of tomengine and blue diamonds and others that do incredible due diligence. I am long and holding.

User Image Gerszon Posted - 13 hours ago

$CLNE $GSAT $NBRV $PTN $RIGL Obit to give you a smile Fanne Foxe, Who Plunged Into the Tidal Basin and Emerged Famous, Dies at 84 https://www.nytimes.com/2021/02/24/us/politics/fanne-foxe-dead.html?action=click&module=News&pgtype=Homepage

User Image Alenstarl Posted - 15 hours ago

$RIGL stay calm, we will be back above 5 before you know it. Was a nice pullback to add

User Image Mao9 Posted - 15 hours ago

$RIGL $rigl$gme$amc

User Image Mao9 Posted - 15 hours ago

$RIGL squeeze to 22.00 next week possible ?